The contribution of copper to the activation of the BRAF/MEK/ERK signaling pathway in melanoma was demonstrated by the finding that the downregulation of SLC31A1 or mutations in MEK1, which disrupt copper binding, resulted in decreased levels of phosphorylated ERK in BRAF-mutant melanomas [52]. Here, SLC31A1 is linked to melanoma.